NCT06638021

Brief Summary

The goal of the clinical trial is to evaluate the preliminary effectiveness and the implementation feasibility of the Targeted EHR-based Communication about Uncertainty (TECU) strategy in improving the quality of care transitions from the emergency department (ED) to home. The overall specific aims related to the trial are to test the preliminary effectiveness of TECU compared to standard of care in reducing patient uncertainty and return ED visits and evaluate the adoption of TECU, exploring patient and clinician barriers and facilitators to TECU implementation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Nov 2024Jul 2027

First Submitted

Initial submission to the registry

February 7, 2024

Completed
8 months until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
21 days until next milestone

Study Start

First participant enrolled

November 5, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

2 years

First QC Date

February 7, 2024

Last Update Submit

April 11, 2025

Conditions

Keywords

Patient uncertaintySymptom-based diagnosisED Discharge CommunicationDiagnostic UncertaintyBest practice advisory

Outcome Measures

Primary Outcomes (1)

  • Uncertainty Scale (U-Scale)

    The Uncertainty Scale (U-Scale) is a 30-item scale designed to measure patient-level uncertainty related to acute symptoms independent of underlying disease. The scale uses a 5-point Likert-style response format, asking respondents to indicate agreement with each statement from "strongly disagree" (1) to "strongly agree" (5) and leading to a nominal score range of 30-150. Higher scores indicate greater uncertainty.

    enrollment

Secondary Outcomes (3)

  • The Care Transition Measure (CTM)-3

    2 days post enrollment

  • Transitions During Uncertainty (TDU) questionnaire

    2 days post enrollment

  • Normalisation MeAsure Development questionnaire (NoMAD)

    At clinician enrollment

Other Outcomes (15)

  • Return emergency department (ED) visits

    9 days post enrollment

  • Return emergency department (ED) visits

    30 days post enrollment

  • Composite healthcare utilization

    30 days post enrollment

  • +12 more other outcomes

Study Arms (2)

Pre-TECU Implementation

NO INTERVENTION

No intervention administered.

Post-TECU Implementation

EXPERIMENTAL

When an ED clinician enters an uncertain diagnosis for a patient being discharged, the TECU BPA will notify the clinician to counsel the patient about uncertainty while additionally triggering automated 1) insertion and printing of the patient handout and 2) provision of a hyperlink for the clinician-facing checklist to guide the discharge conversation.

Behavioral: Targeted EHR-based Communication of Diagnostic Uncertainty (TECU)

Interventions

The Targeted EHR-based Communication about Uncertainty (TECU) strategy will be activated in the electronic health record (Epic) every time an ED clinician enters an uncertain diagnosis for a patient being discharged, and will notify the clinician to counsel the patient about uncertainty while additionally triggering automated 1) insertion and printing of the patient handout and 2) provision of a hyperlink for the clinician-facing checklist to guide the discharge conversation.

Also known as: TECU
Post-TECU Implementation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 years or older
  • English language speaking
  • assigned a symptom-based diagnosis in the EHR clinical impression
  • planned for discharge from the ED during the enrollment visit
  • able to complete follow up assessments in 2 and 30 days
  • TECU best practice advisory (BPA) electronic health record alert activates during their discharge process

You may not qualify if:

  • under the age of 18 years
  • non-English speaking
  • clinically unstable, psychologically impaired or intoxicated, or otherwise unable to provide informed consent as judged by research staff member
  • admitted to hospital
  • unable to complete follow up in 2 and 30 days
  • previously enrolled in this study (during a prior ED visit)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

RECRUITING

Related Publications (1)

  • McCarthy DM, Malone S, Papanagnou D, Leiby BE, Doty AMB, Watts P, Yadav R, Pugliese JK, Woodworth J, Camacho TE, Kean E, Rising KL. Targeted EHR-based communication of diagnostic uncertainty (TECU) in the emergency department: Protocol for an effectiveness implementation trial. Contemp Clin Trials. 2025 Jun;153:107910. doi: 10.1016/j.cct.2025.107910. Epub 2025 Apr 7.

Study Officials

  • Kristin L Rising, MD, MS

    Thomas Jefferson University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kristin L Rising, MD, MS

CONTACT

Amanda MB Doty, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SEQUENTIAL
Model Details: pre-post hybrid type 1 effectiveness implementation design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2024

First Posted

October 15, 2024

Study Start

November 5, 2024

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations